Sprout’s FDA-Approved Contribution To Combating Female HSDD

Sprout Pharmaceuticals, the innovators of Flibanserin, in its dedication to women’s health, is proud to offer the first proven non-hormonal treatment for HSDD. This innovation provides a way for women with a condition that traditionally falls into a taboo social category, regain control of their bodies. So far, there have been no adverse side effects accompanying the great success ADDYI has created. It appears as if Flibanserin is ready to join the hundreds of other pharmaceutical discoveries that have long histories of improving women’s lives.